Notice 4 Sep 2025 finance, regulation, compliance, mergers, federal reserve, acquisitions, bank holding companies

🏦Federal Reserve Notice on Bank Holding Company Mergers and Acquisitions

The Federal Reserve System announces applications for the formation, acquisition, and merger of bank holding companies under the Bank Holding Company Act. The public can inspect applications and provide comments, emphasizing regulatory compliance and transparency. Specific applications for mergers, such as SunMark Bancshares, Inc. with Wheeler Bancshares, Inc., are highlighted for stakeholder awareness.

Learn More
Rule 4 Sep 2025 food additives, incorporation by reference, cultured dairy, reporting and recordkeeping requirements, vitamin d, yogurt, nutrition, compliance, fda

🥛FDA Regulation on Vitamin D in Yogurt

The Food and Drug Administration (FDA or we) is amending the food additive regulations to provide for the safe use of vitamin D<INF>3</INF> as a nutrient supplement in yogurt and other cultured dairy products fermented with Lactobacillus delbrueckii, subspecies bulgaricus (L. delbrueckii, subsp. bulgaricus), and Streptococcus thermophilus (S. thermophilus) at a level higher than is currently permitted. We are taking this action in response to a food additive petition filed by General Mills, Inc. (General Mills or petitioner). We are also updating the reference for the vitamin D<INF>3</INF> specifications.

Learn More
Notice 4 Sep 2025 drug approval, pharmaceutical, regulation, compliance, fda, health

💊FDA Corrects Drug Approval Notice for Bausch & Lomb and Others

The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register on March 14, 2025 (90 FR 49), appearing on page 12163 in FR Doc. 2025-04106. The document announced the withdrawal of approval of eight abbreviated new drug applications (ANDAs) from multiple applicants, withdrawn as of April 14, 2025. The document indicated that FDA was withdrawing approval of the ANDA 075819 for amantadine hydrochloride syrup, 50 milligrams/5 milliliters, held by CMP Pharma, Inc., 8026 East Marlboro Rd., P.O. Box 147, Farmville, NC 27828. Before FDA withdrew the approval of this ANDA, CMP Pharma, Inc., 8026 East Marlboro Rd., P.O. Box 147, Farmville, NC 27828, informed FDA that they did not want the approval of the ANDA withdrawn. Because CMP Pharma, Inc., timely requested that approval of the ANDA not be withdrawn, the approval is still in effect. This notice corrects this error.

Learn More
Notice 4 Sep 2025 injuries, compliance, business operations, safety regulations, federal railroad administration

🚂Notice of Petition for Waiver of Compliance by American Heritage Railways

This document provides the public notice that American Heritage Railways (AHR), on behalf of Durango & Silverton Narrow Gauge Railroad, Great Smoky Mountains Railroad, and Branson Scenic Railway (together, the Railroads), petitioned FRA for relief from certain regulations concerning injury and illness reporting and recordkeeping.

Learn More
Notice 4 Sep 2025 information collection, education, guaranty agencies, compliance, federal regulations

🏫Guaranty Agencies Security Self-Assessment Comment Request Overview

In accordance with the Paperwork Reduction Act (PRA) of 1995, the Department is proposing a revision to a currently approved information collection request (ICR).

Learn More
Notice 4 Sep 2025 financial services, trading, workx, compliance, fees, securities, nasdaq

💰Nasdaq Imposes New Fee for WorkX PRO Monitor Effective September 2025

The SEC has announced a proposed amendment to Nasdaq's exchange fees, specifically introducing a monthly fee for the WorkX PRO Monitor Full Version aimed at enhancing trade reporting efficiency. The new service will improve the price override request process for market participants, allowing for real-time tracking and submissions of trade reports, streamlining compliance with FINRA regulations.

Learn More
Notice 4 Sep 2025 grants, demonstration, hud, fraud prevention, financial reporting, compliance, public comment

💼HUD Notice on Financial Reporting Demonstration for Grant Recipients

Through this notice, HUD solicits comments on a demonstration designed to increase understanding of how enhanced recipient reporting can help reduce the risk of fraud, waste, and abuse across grant programs. The demonstration will focus on testing HUD's design for a reporting portal to collect and analyze supporting financial evidence from recipients, including subrecipient information, to ensure that it is sufficient for its intended purpose. HUD will also refine the portal based on recommendations from participants. The demonstration will allow participants to increase HUD's understanding of the business process changes that may be needed by recipients in this future state. Approximately nine voluntary participants from three HUD grant programs will be included in this demonstration.

Learn More
Notice 4 Sep 2025 fdic, finance, legal, compliance, liquidation, receivership, banking

🏦FDIC Announces Termination of Receiverships for National Republic Bank

The Federal Deposit Insurance Corporation (FDIC) announces the termination of the receivership for National Republic Bank of Chicago following the completion of liquidation and asset distribution. The action signifies the official end of the bank's legal status and involves the FDIC-Corporate assuming necessary legal responsibilities on behalf of the Receiver.

Learn More
Notice 4 Sep 2025 north american electric reliability corporation, federal power act, regulation, compliance, energy

⚡Compliance Review of NERC's Enforcement Programs Overview

The Department of Energy announces the results of a staff review of the North American Electric Reliability Corporation's enforcement programs, including the Find, Fix, Track and Report (FFT) and Compliance Exception (CE) initiatives. The assessment confirms that the programs meet the Commission's expectations, with all sampled noncompliances adequately remediated and risks clearly identified.

Learn More
Notice 4 Sep 2025 madrid protocol, trademark, compliance, ttab, regulatory change, uspto, business law

📄Changes to TTAB Response Times Affect Businesses and Trademark Filings

The Trademark Trial and Appeal Board (TTAB) is revising its practice in setting the initial period of time to answer or submit an acceptable response to a complaint in a TTAB trial proceeding as a result of a re-calculation of time to respond to a provisional refusal pursuant to the Madrid Protocol. Currently, TTAB's established time period for response is forty (40) days from the notice of institution of the TTAB proceeding ("institution order"). The period to file a response is now revised to sixty (60) days from the date of the institution order. This amendment has no impact or effect on the current TTAB Rules of Procedure.

Learn More